Physician profile
Tonya E Buchanan
NPI 1043556467
$1,511.42
in general payments reported to CMS, 2019-2025
13 companies · $23.03 in 2025
The $23.03 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $202 · 2023: $765 · 2024: $296 · 2025: $23.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $268.65 | 2022-2023 | Farxiga, Fasenra |
| Mallinckrodt Hospital Products INC. | $129.51 | 2023 | Terlivaz |
| Neurocrine Biosciences, INC. | $125.15 | 2023 | Ongentys |
| Glaxosmithkline, LLC. | $122.78 | 2022 | |
| Avanir Pharmaceuticals, INC. | $120.00 | 2021 | |
| Abbvie INC. | $117.32 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.09 | 2024 | |
| Viiv Healthcare Company | $112.26 | 2024 | |
| Genentech USA, INC. | $106.00 | 2021 | |
| Novo Nordisk INC | $101.99 | 2023 | Wegovy, Ozempic, Rybelsus |
| Tactile Systems Technology INC | $101.44 | 2023 | Flexitouch Plus, Entre Plus |
| Teva Pharmaceuticals USA, INC. | $70.20 | 2024 | Austedo Xr |
| Exact Sciences Corporation | $23.03 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.